What does CUSIP 29664W105 represent in this 13F holders report?

CUSIP 29664W105 is the security identifier for ESPR - Esperion Therapeutics, Inc. - COM used to aggregate holder disclosures.

How many institutions held ESPR - Esperion Therapeutics, Inc. - COM in Q4 2017?

163 institutional investors reported ESPR - Esperion Therapeutics, Inc. - COM for Q4 2017. Use the holders table for investor-level position and value details.

Esperion Therapeutics, Inc. - COM (ESPR)

CUSIP: 29664W105

Q4 2017 13F Holders as of 31 Dec 2017

Security type / class: Equity / COM
Shares outstanding: 258,506,508
Total 13F shares: 24,011,278
Share change: +102,949
Total reported value: $1,580,908,389
Put/Call ratio: 106%
Reported price per share: $65.84
Number of holders: 163
Value change: +$28,478,384
Number of buys: 83
Number of sells: 78

Security key

29664W105

Report period

Q4 2017

Institutions

163

Top holders

ESPR full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2018 Previous quarter: Q3 2017 Esperion Therapeutics, Inc. SEC filings Esperion Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 29664W105

Newer quarter: Q1 2018 Previous quarter: Q3 2017

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Meditor Group Ltd

13D/G signal

—

Evidence rows

Latest as of

30 Sep 2017

13F Lead comparable stake: 0.89% Showing first 8 of 50 holder rows. Open remaining rows

Rank 1 holder

Meditor Group Ltd

13F

Ownership: 0.89%
Position: $115.02M

13F

Rank 2 holder

Pentwater Capital Management LP

13F

Ownership: 0.87%
Position: $112.43M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Meditor Group Ltd	13F Company 13F	0.89%	$115,022,000 2,294,935 shares	—	30 Sep 2017
Pentwater Capital Management LP	13F Company 13F	0.87%	$112,429,000 2,243,200 shares	—	30 Sep 2017
BB BIOTECH AG	13F Company 13F	0.81%	$105,150,000 2,097,964 shares	—	30 Sep 2017
BlackRock Finance, Inc.	13F Company 13F	0.59%	$76,267,000 1,521,674 shares	—	30 Sep 2017
FMR LLC	13F Company 13F	0.52%	$67,306,000 1,342,888 shares	—	30 Sep 2017
STATE STREET CORP	13F Company 13F	0.49%	$63,166,000 1,260,414 shares	—	30 Sep 2017
CREDIT SUISSE AG/	13F Company 13F	0.41%	$53,330,000 1,064,038 shares	—	30 Sep 2017
VANGUARD GROUP INC	13F Company 13F	0.34%	$44,121,000 880,323 shares	—	30 Sep 2017

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Aisling Capital LLC	13F Company 13F	0.32%	$41,957,000 837,125 shares	—	30 Sep 2017
DISCOVERY CAPITAL MANAGEMENT, LLC / CT	13F Company 13F	0.3%	$39,247,000 783,059 shares	—	30 Sep 2017
PINNACLE ASSOCIATES LTD	13F Company 13F	0.28%	$35,977,000 717,813 shares	—	30 Sep 2017
WASATCH ADVISORS LP	13F Company 13F	0.28%	$35,756,000 713,404 shares	—	30 Sep 2017
NORTHERN TRUST CORP	13F Company 13F	0.22%	$28,965,000 577,917 shares	—	30 Sep 2017
PFM Health Sciences, LP	13F Company 13F	0.21%	$27,500,000 548,682 shares	—	30 Sep 2017
Boxer Capital, LLC	13F Company 13F	0.19%	$25,060,000 500,000 shares	—	30 Sep 2017
BALYASNY ASSET MANAGEMENT L.P.	13F Company 13F	0.15%	$19,705,000 393,150 shares	—	30 Sep 2017
Rhenman & Partners Asset Management AB	13F Company 13F	0.12%	$15,628,000 311,803 shares	—	30 Sep 2017
PICTET ASSET MANAGEMENT LTD	13F Company 13F	0.12%	$15,360,000 306,455 shares	—	30 Sep 2017
PEREGRINE CAPITAL MANAGEMENT LLC	13F Company 13F	0.11%	$14,536,000 290,027 shares	—	30 Sep 2017
Aviva Holdings Ltd.	13F Company 13F	0.11%	$14,490,000 289,100 shares	—	30 Sep 2017
GOLDMAN SACHS GROUP INC	13F Company 13F	0.1%	$12,986,000 259,096 shares	—	30 Sep 2017
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC	13F Company 13F	0.1%	$12,583,000 250,000 shares	—	30 Sep 2017
LORD, ABBETT & CO. LLC	13F Company 13F	0.09%	$11,823,000 235,889 shares	—	30 Sep 2017
GAM Holding AG	13F Company 13F	0.09%	$11,277,000 225,000 shares	—	30 Sep 2017
BNP PARIBAS FINANCIAL MARKETS	13F Company 13F	0.08%	$10,097,977 201,476 shares	—	30 Sep 2017
AMUNDI ASSET MANAGEMENT US, INC.	13F Company 13F	0.07%	$9,517,000 189,899 shares	—	30 Sep 2017
MUFG Securities EMEA plc	13F Company 13F	0.07%	$9,022,000 180,000 shares	—	30 Sep 2017
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.07%	$8,851,000 176,611 shares	—	30 Sep 2017
Invesco Ltd.	13F Company 13F	0.07%	$8,726,000 174,097 shares	—	30 Sep 2017
CREDIT AGRICOLE S A	13F Individual 13F	0.06%	$7,914,000 157,900 shares	—	30 Sep 2017
Iguana Healthcare Management, LLC	13F Company 13F	0.06%	$7,518,000 150,000 shares	—	30 Sep 2017
TEACHERS ADVISORS, LLC	13F Company 13F	0.06%	$7,166,000 142,981 shares	—	30 Sep 2017
Quantitative Investment Management, LLC	13F Company 13F	0.05%	$6,194,000 123,600 shares	—	30 Sep 2017
DEUTSCHE BANK AG\	13F Company 13F	0.05%	$5,912,000 117,987 shares	—	30 Sep 2017
Bank of New York Mellon Corp	13F Company 13F	0.04%	$5,783,000 115,372 shares	—	30 Sep 2017
UBS Group AG	13F Company 13F	0.04%	$5,223,000 104,191 shares	—	30 Sep 2017
AQR CAPITAL MANAGEMENT LLC	13F Company 13F	0.04%	$5,199,000 103,726 shares	—	30 Sep 2017
Informed Momentum Co LLC	13F Company 13F	0.04%	$4,656,000 92,899 shares	—	30 Sep 2017
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F Company 13F	0.04%	$4,604,000 91,843 shares	—	30 Sep 2017
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F Company 13F	0.04%	$4,585,000 91,480 shares	—	30 Sep 2017
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	0.04%	$4,548,000 90,750 shares	—	30 Sep 2017
SABBY MANAGEMENT, LLC	13F Company 13F	0.03%	$4,178,000 83,357 shares	—	30 Sep 2017
S.c.a. Candriam	13F Individual 13F	0.03%	$4,010,000 80,000 shares	—	30 Sep 2017
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	0.03%	$3,928,000 78,364 shares	—	30 Sep 2017
BAILARD, INC.	13F Company 13F	0.02%	$3,173,000 63,300 shares	—	30 Sep 2017
JPMORGAN CHASE & CO	13F Company 13F	0.02%	$3,087,000 61,800 shares	—	30 Sep 2017
CITADEL ADVISORS LLC	13F Company 13F	0.02%	$2,924,000 58,332 shares	—	30 Sep 2017
GUGGENHEIM CAPITAL LLC	13F Company 13F	0.02%	$2,761,000 55,095 shares	—	30 Sep 2017
COLUMBUS CIRCLE INVESTORS	13F Company 13F	0.02%	$2,606,000 51,997 shares	—	30 Sep 2017
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F Company 13F	0.02%	$2,473,000 49,335 shares	—	30 Sep 2017

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

163

24,011,278

Rows loaded

163

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders

150

Q4 2017 holders

163

Holder diff

Investor	Q3 2017 Shares	Q4 2017 Shares	Share Diff	Share Chg %	Q3 2017 value	Q4 2017 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

Esperion Therapeutics, Inc. - COM (ESPR)

Q4 2017 13F Holders as of 31 Dec 2017

Holder history for CUSIP 29664W105

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Meditor Group Ltd

Pentwater Capital Management LP

BB BIOTECH AG

Institutional holders as of Q4 2017

Compare Q4 2017 vs Q3 2017 Across Filers